Sie suchten nach: selamectin (Englisch - Maltesisch)

selamectin
selamektin

240 mg selamectin
240 mg selamektin

qp54a a05 selamectin
qp54a a05 selamektin

mg of selamectin dispensed
mg ta’ selamektin mogħtija

selamectin 45 mg selamectin 60 mg
selamektin 45 mg selamektin 60 mg

selamectin selamectin selamectin selamectin selamectin
selamektin selamektin selamektin selamektin selamektin

six tubes each containing 0.25 ml (30 mg selamectin).
sitt tubi li fihom 0. 25 ml (30 mg selamektin) kull wieħed.

three tubes each containing 0.25 ml (15 mg selamectin).
tliet tubi li fihom 0. 25 ml (15 mg selamektin) kull wieħed.

selamectin has adulticidal, ovicidal and larvicidal activity against fleas.
selamektin joqtol il-forma adulta, il-bajd u l-larvi tal-briegħed.

stronghold is an antiparasitic medicine that contains the active substance selamectin.
stronghold huwa mediċina antiparassitika li fiha s-sustanza attiva s-selamektin.

the comparator was selamectin in cats, and milbemycin oxime and praziquantel in dogs.
il- mediċina tat- tqabbil (comparator) kien is- selamektina (selamectin) għall- qtates u milbemycin oxime u praziquantel għall- klieb.

stronghold 15 mg spot-on solution for cats and dogs < 2.5 kg selamectin
stronghold 15 mg soluzzjoni għal użu topikali għall-qtates u l-klieb < 2.5 kg.

selamectin may adversely affect fish or certain water-borne organisms on which they feed.
selamektin jista’ jkollha effett ħażin fuq il-ħut jew fuq ċerti ħlejjaq ta’ l-ilma li jservu bħala ikel għall- ħut.

stronghold contains selamectin, which is an antiparasitic medicine that belongs to the ‘avermectin’ class.
stronghold fih is-selamektin, li hi mediċina antiparassitika li tagħmel parti mill-klassi magħrufa bħala ‘avermektin’.

following spot on administration selamectin is absorbed from the skin reaching maximum plasma concentrations approximately 1 and 3 days after administration in cats and dogs respectively.
wara li tingħata b’mod topikali, selamektin tiġi assorbita mil-ġilda u tilħaq l-ogħla livelli fid-demm, bejn wieħed u ieħor ġurnata wara li tkun ingħatat lill-qtates u tlett-ijiem wara li tkun ingħatat lill-klieb.

a field study in japan involved cats with flea infestations which were either treated with broadline or a spot-on medicine containing the active substance selamectin.
studju fuq il-post fil-Ġappun involva qtates b’infestazzjonijiet bil-briegħed li jew ġew ikkurati bi broadline jew b’mediċina għall-użu lokalizzat li fiha s-sustanza attiva selamectin.

selamectin activates special proteins called ‘chloride channels’ on the surface of nerve and muscle cells, disrupting their normal electrical activity.
selamectin jattiva proteini speċjali magħrufa bħala ‘ kanali tal - klorur ’ fuq is- superfiċje taċ- ċelloli tan- nervituri u tal- muskoli, u b’ hekk iħarbtu l- attività elettrika normali.

the systemic persistence of selamectin in plasma and the lack of extensive metabolism provide effective concentrations of selamectin for the duration of the inter-dosing interval (30 days).
il-persistenza sistemika tas-selamektin fid-demm u n-nuqqas ta’ metaboliżmu estensiv iwasslu għal saħħa effettiva biżżejjed fil-perjodu ta’ bejn doża u oħra (30 ġurnata).

stronghold 30 mg spot-on solution for dogs 2.6–5.0 kg stronghold 60 mg spot-on solution for dogs 5.1–10.0 kg stronghold 120 mg spot-on solution for dogs 10.1–20.0 kg stronghold 240 mg spot-on solution for dogs 20.1–40.0 kg stronghold 360 mg spot-on solution for dogs 40.1–60.0 kg selamectin
stronghold 30 mg soluzzjoni għal użu topikali għall-klieb 2.6-5.0 kg stronghold 60 mg soluzzjoni għal użu topikali għall-klieb 5.1-10.0 kg stronghold 120 mg soluzzjoni għal użu topikali għall-klieb 10.1-20.0 kg stronghold 240 mg soluzzjoni għal użu topikali għall-klieb 20.1-40.0 kg stronghold 360 mg soluzzjoni għal użu topikali għall-klieb 40.1-60.0 kg selamektin